Skip to Main Content


  • Metastasis (colon, breast, neuroendocrine).
  • Hepatocellular carcinoma.
  • Cholangiocarcinoma.
  • Hepatoblastoma.
  • Gallbladder carcinoma.
  • Hepatic sarcoma.
  • Adenoma.
  • Biliary cystadenoma.
  • Symptomatic hemangioma or focal nodular hyperplasia.
  • Hepatic tumor of unknown etiology.


  • Distant metastatic disease for primary liver tumors.
  • Presence of extrahepatic metastases for metastatic lesions (relative).
  • Severe medical comorbidity.
  • Inability to achieve negative margins.
  • Insufficient estimated liver remnant following resection.
  • Significant cirrhosis or portal hypertension.


  • The patient should be supine with arms extended.


  • Adequacy of resuscitation should be monitored closely, and any concern for bleeding should be promptly evaluated.
  • Assessment of liver function should be followed closely in the postoperative period (neurologic status, coagulation factors, liver function tests).
  • Benzodiazepines and hepatotoxic medications should be avoided in the early postoperative period.
  • Deep vein thrombosis prophylaxis should be provided.
  • Oral diet can be advanced as tolerated; if not tolerated, other forms of enteral nutrition should be initiated.
  • Close monitoring for possible complications is required (see later).


  • Bleeding.
  • Bile leak.
    • Manifested by bile staining in drains or evidence of cholestasis on liver function tests.
    • Symptoms may involve increased abdominal pain, ileus, fever, or tachycardia.
    • Many bile leaks are self limited and can be treated with percutaneous drainage alone.
    • More severe bile leaks will require endoscopic retrograde cholangiopancreatography (ERCP) with sphincterotomy and biliary stent placement, or placement of a percutaneous transhepatic cholangiocatheter (PTC) in situations where ERCP is not technically possible.
  • Abscess or infection.
  • Hepatic dysfunction, which can be manifested by the following:
    • Acidosis.
    • Impaired mental status.
    • Hypoglycemia.
    • Coagulopathy.
    • Hyperbilirubinemia.
    • Transaminitis.
    • Renal failure.
    • Predisposition to infection.
    • Care is primarily supportive, but evaluation should be performed to exclude major biliary or vascular complications.
  • Tumor recurrence.
  • Embolism (usually intraoperative).
    • Can be diagnosed using intraoperative transesophageal echocardiography if necessary.
    • Prevented by optimizing CVP during parenchymal dissection.

Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.


About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Subscription Options

AccessAnesthesiology Full Site: One-Year Subscription

Connect to the full suite of AccessAnesthesiology content and resources including procedural videos, interactive self-assessment, real-life cases, 20+ textbooks, and more

$995 USD
Buy Now

Pay Per View: Timed Access to all of AccessAnesthesiology

24 Hour Subscription $34.95

Buy Now

48 Hour Subscription $54.95

Buy Now

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.